Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China on the warpath of illegal advertising of healthcare products

This article was originally published in Clinica

Executive Summary

The Chinese State Food and Drug Administration has reported in the first quarter of this year it discovered 3,239 illegal advertisements for medical instruments. This, however, is only a fraction of the 33,648 illegal ads for drugs which it uncovered during the same period. The SFDA added that it revoked several advertising licenses – 15 in relation to drugs, though none were mentioned with regard to medical devices – for offences including releasing the ads without prior approval from the regional regulatory authorities and illegally making changes to previously approved content. The SFDA also said that in 11 instances, it temporarily suspended sales of certain products mentioned in the illegal ads.

Topics

UsernamePublicRestriction

Register

MT098869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel